RETRACTED: Variation of some inflammatory markers in hypertensive patients after 1 year of olmesartan/amlodipine single-pill combination compared with olmesartan or amlodipine monotherapies

This publication has 31 references indexed in Scilit:

• Effect of Telmisartan on Paroxysmal Atrial Fibrillation Recurrence in Hypertensive Patients With Normal or Increased Left Atrial Size
  Clinical Cardiology, 2012
• Differential effects of candesartan and olmesartan on adipose tissue activity biomarkers in type II diabetic hypertensive patients
  Hypertension Research, 2010
• Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
  Journal Of Hypertension, 2009
• Comparative Effects of Telmisartan and Eprosartan on Insulin Sensitivity in the Treatment of Overweight Hypertensive Patients
  Hormone and Metabolic Research, 2009
• Heart Disease and Stroke Statistics—2009 Update
  Circulation, 2009
• Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan – amlodipine combination
  Vascular Health and Risk Management, 2008
• Effect of Delapril/Manidipine vs Olmesartan/ Hydrochlorothiazide Combination on Insulin Sensitivity and Fibrinogen in Obese Hypertensive Patients
  Internal Medicine, 2008
• Metabolic effects of telmisartan and irbesartan in type 2 diabetic patients with metabolic syndrome treated with rosiglitazone
  Journal of Clinical Pharmacy and Therapeutics, 2007
• Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999–2004
  Hypertension, 2007
• Telmisartan and Irbesartan Therapy in Type 2 Diabetic Patients Treated with Rosiglitazone: Effects on Insulin-Resistance, Leptin and Tumor Necrosis Factor-.ALPHA.
  Hypertension Research, 2006